MDA Space Heads Into Q3 Print With an Activist on the Register

An activist investor holding nearly 10% of MDA Space is the most consequential fact heading into Wednesday's earnings release, arriving as the stock trades at its weakest level in months.

MARISELLE A.S. filed a Schedule 13D on October 14, disclosing a 9.5% stake of 15.4 million shares. A 13D filing signals active rather than passive intent, making it the highest-signal entry on MDA's register. That stake was added in one move: this is a first-and-only filing, with no prior 13G to amend. PPF Group a.s. sits alongside it with a 7.8% passive 13G position. Together, the two largest holders control more than 17% of the company. As always with 13D/G disclosures, these stakes reflect positions as last reported around the 5% threshold; a holder dropping below that level may not file again. The activist arrival gives Wednesday's print a dimension beyond the quarterly numbers alone.

The stock's recent trajectory complicates the picture. MDA has fallen 14% over the past month to CAD 36.72, with nearly 8% of that loss coming in the past week. The broader peer group has also weakened: RKLB, RDW and LUNR each dropped more than 7% on Monday alone. The sector-wide move suggests macro or risk-appetite pressure rather than MDA-specific news, but the stock is still underperforming a recent note that flagged a 62.8% year-to-date gain. That gain has been substantially trimmed.

Short interest carries a sharp internal contrast. At 9.75% of free float, the short position is genuinely elevated. But it has dropped 41% over the past month, from roughly 21 million shares to 12.3 million. The ORTEX short score has eased from above 70 in mid-October to 58.8 now. Borrow conditions are relaxed: availability is at 235%, meaning there are more than two shares available to lend for every one already borrowed, and borrowing costs have fallen to 0.82%, down a third over the past month. The lending market is not the source of pressure; it looks like a covering event, not a squeeze, and the covering came precisely as the activist stake was disclosed.

The valuation reset is also notable. The price-to-earnings multiple has compressed by nearly four points over the past month to 20.4x, and EV/EBITDA has dropped 0.7 turns to 10.3x. Both are moving in the direction of a more defensible entry point, though the EPS surprise factor score of 27 is a caution: the company has not been a consistent beat, even as forward earnings momentum scores in the 76th to 84th percentile on 30- and 90-day windows. Analyst price targets are stale (last updated in July) and should not be relied upon at face value.

The print on November 5 will therefore test whether the operational momentum that drove the stock's earlier 2026 rally has held through Q3, and whether the numbers give the new activist a clean foundation to build on or a reason to push for change.